Literature DB >> 32169135

Are Lipoprotein Levels and Ratios Able to Predict Mortality due to Sepsis?

Irfan Karahan1, Aydin Cifci1.   

Abstract

OBJECTIVE: To compare lipoprotein levels, and non-HDL to high-density lipoprotein (HDL) ratios of survivors and nonsurvivors of sepsis, and to determine the predictivity levels of specified parameters in mortality. STUDY
DESIGN: Descriptive study. PLACE AND DURATION OF STUDY: Department of Internal Medicine, Kirikkale University, School of Medicine, Training and Research Hospital, Kirikkale, Turkey, from December 2017 to December 2018.
METHODOLOGY: The study subjects included 37 non-survivors and 32 survivors of sepsis with similar ages, comorbidities, and disease activities. The total lipoprotein levels, and non-HDL to HDL ratios of the participants were compared retrospectively.
RESULTS: HDL and non-HDL to HDL ratios were found to be different between the two groups. The cut-off levels of these values were determined as 32 and 3.4, respectively. The cut-off levels found in the study suggest that the low HDL levels and high non-HDL to HDL ratios significantly increase the mortality risk for patients (OR=1.8 and 3.45, respectively).
CONCLUSION: Non-HDL to HDL ratio may be used as a useful tool for predicting sepsis mortality. These values may also be included as a part of scoring systems. Further investigations are needed to clarify the role of lipoproteins in sepsis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32169135     DOI: 10.29271/jcpsp.2020.03.272

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  1 in total

1.  Hydrogen Attenuates Endotoxin-Induced Lung Injury by Activating Thioredoxin 1 and Decreasing Tissue Factor Expression.

Authors:  Qian Li; Liang Hu; Juan Li; Pan Yu; Fan Hu; Bing Wan; Miaomiao Xu; Huixian Cheng; Wanyou Yu; Liping Jiang; Yadan Shi; Jincan Li; Manlin Duan; Yun Long; Wen-Tao Liu
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.